Robotic radiosurgery for the treatment of one to three brain metastases: A pragmatic application of cost-benefit analysis using willingness to pay.

2012 ◽  
Vol 30 (34_suppl) ◽  
pp. 17-17
Author(s):  
Jeffrey Noah Greenspoon ◽  
Waseem Sharieff ◽  
Anthony Whitton ◽  
Timothy Joseph Whelan ◽  
Jim R. Wright ◽  
...  
Keyword(s):  
Brain Metastases ◽  
Willingness To Pay ◽  
Incremental Cost ◽  
New Technologies ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Decision Makers ◽  
Benefit Analysis ◽  
Robotic Radiosurgery ◽  
Starting Point

17 Background: With the emergence of radiosurgery as a new radiotheraputic technique, health care decision makers are required to incorporate community need, cost and patient preferences when allocating radiosurgery resources. Conventional patient utility measures would not reflect short term preferences and would therefore not inform decision makers when allocating radiosurgery treatment units. The goal of this article is to demonstrate the feasibility of cost-benefit analysis to elicit the yearly net monetary benefit of robotic radiosurgery. Methods: To calculate the yearly incremental cost of robotic radiosurgery as compared to fixed-gantry radiosurgery we used direct local cost data. We assumed a standard 10 year replacement and 5% amortization rate. Decision boards summarizing the clinical scenario of brain metastases and the difference between robotic and fixed-gantry radiosurgery in terms of immobilization, comfort and treatment time were then presented to a sample of 18 participants. Participants who preferred robotic radiosurgery were randomly assigned to either a low ($1) or high ($5) starting point taxation based willingness-to-pay algorithm. Results: The yearly incremental cost of providing robotic radiosurgery was $99,177. The mean community yearly willingness-to pay for robotic radiosurgery was $2,300,000, p=0.03. The calculated yearly net societal benefit for robotic radiosurgery was $2,200,823. Among participants who preferred robotic radiosurgery there was no evidence of starting point bias, p=0.8. Conclusions: We have shown through this pilot study that it is feasible to perform cost-benefit analysis to evaluate new technologies in Radiation Oncology. Cost-benefit analysis offers an analytic method to evaluate local preferences and provide accountability when allocating limited healthcare resources.

Robotic Radiosurgery for the Treatment of 1–3 Brain Metastases: A Pragmatic Application of Cost-Benefit Analysis Using Willingness-To-Pay

2013 ◽  
Vol 12 (6) ◽  
pp. 517-523 ◽  
Author(s):  
Jeffrey Noah Greenspoon ◽  
Anthony Whitton ◽  
Timothy Whelan ◽  
Waseem Sharieff ◽  
James Wright ◽  
...  
Keyword(s):  
Brain Metastases ◽  
Willingness To Pay ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Benefit Analysis ◽  
Robotic Radiosurgery

Inclusion of Social Subsystem Issues in IT Investment Decisions

2011 ◽  
pp. 164-183
Author(s):  
Sherry D. Ryan ◽  
Michael S. Gates
Keyword(s):  
Survey Data ◽  
Decision Process ◽  
Cost Benefit Analysis ◽  
Investment Decisions ◽  
Cost Benefit ◽  
Decision Makers ◽  
Benefit Analysis ◽  
Analysis Model ◽  
Decision Criteria ◽  
The Social

Researchers have attempted to augment the traditional cost/benefit analysis model used in the IT decision process. However, frequently social subsystem issues are inadequately considered. Survey data, collected from a U.S. sample of 200 executives, provides an empirical assessment of how these issues compare with other IT decision criteria given differing decision types. The social subsystem issues considered most important by decision makers are also identified and the manner by which they consider these issues is investigated.

The Concept of Cost in the Economic Evaluation of Health Care: A Theoretical Inquiry

1994 ◽  
Vol 10 (4) ◽  
pp. 675-682 ◽  
Author(s):  
Magnus Johannesson
Keyword(s):  
Health Care ◽  
Economic Evaluation ◽  
Willingness To Pay ◽  
Treatment Program ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Economic Evaluations ◽  
Benefit Analysis ◽  
Full Economic Evaluation ◽  
The Individual

AbstractThe costs included in economic evaluations of health care vary from study to study. Based on the theory of cost-benefit analysis, the costs that should be included in an economic evaluation are those not already included in the measurement of willingness to pay (net willingness to pay above any treatment costs paid by the individual) in a cost-benefit analysis or in the easurement of effectiveness in a cost-effectiveness analysis. These costs can be defined as the onsumption externality of the treatment (the change in production minus consumption for those included in the treatment program). For a full economic evaluation, the consequences for those included in the treatment program and a caring externality (altruism) should also be added.

Cost/Benefit Analysis

1973 ◽  
Vol 19 (3) ◽  
pp. 315-322
Author(s):  
John E. Tropman ◽  
Karl H. Gohlke
Keyword(s):  
Information System ◽  
Interest Groups ◽  
Justice System ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Decision Makers ◽  
Accurate Information ◽  
Benefit Analysis ◽  
Organizational Goals ◽  
Style Of Thought

The techniques of cost/benefit analysis are presented in a general way in order to encourage decision-makers in the crim inal justice system to adopt a style of thought that will assist them in formulating decisional alternatives. Discussion of the promises and pitfalls of the technique addresses the question of whether the "benefits" of cost/benefit analysis are sufficient to outweigh the "costs" in its adoption. The authors contend that the technique can be quite useful to executives in their quest to manage their organizations toward the achievement of organizational goals because the technique will enable them to identify new programs worthy of experimentation, will encour age the development of an accurate information system, will en hance their ability to base programatic decisions on community and social indicatcrs, and will better equip them in their rela tionships with legislators, funding bodies, and interest groups.

scholarly journals Mortality-risk valuation, age and cause of death: out-of-hospital cardiac arrest

2017 ◽  
Vol 5 (2) ◽  
pp. 28-40
Author(s):  
Björn Sund
Keyword(s):  
Cardiac Arrest ◽  
Willingness To Pay ◽  
Cause Of Death ◽  
Road Traffic ◽  
Cost Benefit Analysis ◽  
Stated Preference ◽  
Cost Benefit ◽  
Transport Sector ◽  
Benefit Analysis ◽  
Hospital Cardiac Arrest

Economic evaluation of policies regarding out-of-hospital cardiac arrest (OHCA) is important. The value of a statistical life (VSL) for OHCA victims is the most important component in a cost-benefit analysis of interventions that have the possibility to reduce mortality from this cause. This value is not known. We use responses to a national Swedish mail survey, based on the stated-preference technique to directly elicit individuals’ hypothetical willingness to pay for a reduced risk of dying from OHCA. A lower-bound estimate of VSL for OHCA would be in range of SEK 30 to 50 million. The value is found to be higher than for comparable VSL estimates from the transport sector, even though individuals who suffer OHCAs are generally older and less healthy than people who die in road traffic accidents. The results indicate that it is not an overestimation to use the ‘baseline’ VSL value from the transport sector (SEK 24 million) in cost-benefit analysis of OHCA policy decisions and that the cause of death is important when examining willingness to pay for death risk reductions. We do not support a general declining VSL due to the age of the victims, i.e. a ‘senior death discount’, for this cause of death.Published: Online January 2017. In print December 2017.

Welfare considerations in future selection and management strategies

1995 ◽  
Vol 19 ◽  
pp. 87-93 ◽  
Author(s):  
A. J. F. Webster
Keyword(s):  
New Technologies ◽  
Cost Benefit Analysis ◽  
Management Strategies ◽  
Cost Benefit ◽  
Benefit Analysis ◽  
Genetic Progress ◽  
Grass Silage ◽  
Welfare Implications ◽  
Physiological Demands ◽  
The Cost

AbstractThis paper considers the welfare implications of breeding, feeding and managing dairy cows for increased productivity. The physiological demands of lactation for the high genetic merit dairy cow are exceptional, less in their intensity and more in their duration. Most welfare problems can be attributed less to productivity per se than to systems of feeding, milking and management that are unsuitable to the genotype of the high yielding cow. These include the inadequacies of wet grass silage as a staple food and the abnormal restriction of cows to twice-daily milking. It is also necessary to consider welfare problems that may arise from the application of new technologies to increase milk yield or to increase the rate of genetic progress. These may be related to the process itself or to its consequences. It is proposed that the commercial exploitation of these new technologies should be controlled by legislation similar to that for the protection of animals used for scientific purposes which applies a cost-benefit analysis to determine whether the cost to the animal can be justified in terms of any potential benefit to society.

Sign in / Sign up

Export Citation Format

Share Document